文献速递肿瘤 PET/CT神经核医学

鳞状细胞癌在68Ga-DOTATATE PET/CT中模拟颈部副神经节瘤

Squamous Cell Carcinoma Mimicking Neck Paraganglioma on 68Ga-DOTATATE PET/CT.
PubMed 文献 · Clin Nucl Med · 2021-01-01

本文报道一例50岁男性因怀疑副神经节瘤行68Ga-DOTATATE PET/CT,显示颈内静脉链病灶生长抑素受体活性增高;活检证实为鳞状细胞癌淋巴结转移而非副神经节瘤,18F-FDG PET/CT显示喉部原发恶性肿瘤及淋巴结转移并经手术证实。提示SSTR显像存在假阳性可能。

要点

  • 68Ga-DOTATATE PET/CT中颈部SSTR高摄取病灶需鉴别鳞状细胞癌淋巴结转移。
  • 活检是区分副神经节瘤与其他SSTR高表达恶性肿瘤的关键。
  • 18F-FDG PET/CT有助于寻找原发灶并辅助诊断。

核心结论

  • 68Ga-DOTATATE PET/CT中颈部病灶SSTR活性增高并非副神经节瘤特异,鳞状细胞癌淋巴结转移可表现为假阳性。

研究设计与样本

  • 单例病例报告:50岁男性,因怀疑副神经节瘤行68Ga-DOTATATE PET/CT。

主要发现

  • 68Ga-DOTATATE PET/CT显示颈内静脉链颈部病灶SSTR活性增高。
  • 活检证实为鳞状细胞癌淋巴结转移,而非副神经节瘤。
  • 18F-FDG PET/CT显示喉部原发恶性肿瘤及淋巴结转移,并经手术证实。

临床怎么用

  • 对68Ga-DOTATATE PET/CT颈部SSTR高摄取病灶应结合活检及18F-FDG PET/CT鉴别诊断,避免误诊为副神经节瘤。

局限性

  • 单例病例报告,结论的普遍适用性有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Somatostatin receptor (SSTR) imaging with 68Ga-labeled somatostatin analogs has been used for many tumors with high SSTR expression. Increased uptake mostly depends on the SSTR status of tumors; however, false-positive uptake can be demonstrated in benign diseases or other malignancies because of the increased SSTR expression. We present a case of a 50-year-old man with increased SSTR activity on cervical lesion located in internal jugular chain in 68Ga-DOTATATE PET/CT, which was performed for suspicion of paraganglioma. Biopsy revealed lymph node metastasis of squamous cell carcinoma other than paraganglioma. 18F-FDG PET/CT showed primary malignancy on larynx and lymph node metastasis, which were correlated surgically.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Civan C, Isik EG, Has Simsek D, et al. Squamous Cell Carcinoma Mimicking Neck Paraganglioma on 68Ga-DOTATATE PET/CT. Clin Nucl Med. 2021. PMID: 33630807. doi:10.1097/RLU.0000000000003555

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。